Overview
BioAsia 2026 is one of Asia’s premier life sciences and health-tech forums, hosted by the government of Telangana and bringing together global leaders across biopharma, healthcare, technology, and policy. Under the theme “TechBio Unleashed — AI, Automation And The Biology Revolution,” the forum explores how the convergence of biology, AI, and automation is transforming drug discovery, diagnostics, advanced therapies, and healthcare delivery. With over two decades of legacy, BioAsia has evolved into a platform for strategic partnerships, cross-border collaboration, and industry-shaping dialogue.
We were proud to be the CEO Conclave Sponsor, an exclusive, invite-only forum convening global CEOs for a candid, forward-looking dialogue on the innovation, growth and transformation shaping the life sciences industry over the next decade.
Session
February 17, 06:00 p.m.—07:30 p.m. IST
CEO Conclave — Imperatives For Biopharma CEOs In India
As the Indian pharmaceutical industry reaches an important inflection point, leaders must rethink how they drive the next phase of value creation. Our session will explore the strategic choices CEOs need to make as traditional models mature and new opportunities emerge.
Key topics discussed:
- While the US remains a significant profit pool, identifying where the next waves of sustainable growth will come from is a critical priority.
- How innovative products can move from promise to scale, replicating the success of India’s generics platforms.
- What it takes to harness artificial intelligence (AI) meaningfully across the enterprise to unlock measurable value.
- As corporate portfolios evolve, identifying adjacent opportunities with the potential to deliver the highest shareholder returns is increasingly important.
Speakers: Chirag Adatia, partner, Health and Life Sciences Practice, Oliver Wyman
Meet The Team
